Chyme reinfusion reduces complications after surgical reconstruction

A meta-analysis of five studies with 460 patients revealed that chyme reinfusion (CR) significantly lowers overall complications (odds ratio 0.25) and specifically ileus (odds ratio 0.35) and diarrhea (odds ratio 0.29) in patients undergoing reconstruction for high-output ostomies and enterocutaneous fistulas. Additionally, CR notably shortens hospital stays and reduces inflammatory markers like C-reactive protein and white blood cell counts, suggesting its efficacy as a supportive procedure in postoperative care.